Research and Markets: This Global Protein Therapeutics Market Analysis Forecasts the Industry to Grow at a CAGR of 12% dur

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/9bdf9d/global_protein_the) has announced the addition of the "Global Protein Therapeutics Market Analysis" report to their offering.

Protein therapeutics is one of the fast growing markets globally. Rising ageing population along with increasing prevalence of chronic diseases such as, cancer, diabetes, cardiovascular diseases, and rising penetration of medical insurance are some of the prominent factors that are driving the superfluous growth of the industry. In addition, protein therapies have been playing a significant role in the development of modern treatment methodology, which, in turn, has effectively addressed the roots of many diseases. As a result, the attractiveness of protein-based pharmaceuticals has brought in market many large and small players in this sector.

According to this new research report Global Protein Therapeutics Market Analysis, the global protein therapeutics market is expected to grow at a CAGR of around 12% during 2011-2013. Various factors such as, introduction of new protein therapeutics and enhanced investments will contribute to the buoyant growth of this industry. Besides, augmentation in the number of clinical trials will surface the optimistic performance of the industry.

This study indicates that, the major segments in protein therapeutics market such as, Monoclonal antibody, Insulin, Interferon Beta, G-CSF, coagulation factors etc. are the major revenue generators for the industry. However, presently, monoclonal antibody, dominates the global protein therapeutics market as large numbers of players have been directing their efforts to develop innovative treatments using mAbs.

As per the research, fast growth in protein therapeutics will also strengthen other emerging sectors. For instance, Bio-generics will represent a key future growth segment, which is expected to be a multi-billion dollar market. Patent expiration of leading biotech drugs in future will create one of the biggest opportunities in the field of bio-generics.

The report provides extensive information and rational analysis of the global protein therapeutics market. It has thoroughly examined current market trends, industrial developments, and competitive landscape to enable clients understand the market structure and its progress in coming years. The forecast presented in the report is based on correlation between the market trends and drivers.

Key Topics Covered:

1. Analyst View

2. Global Proteins Therapeutic Market

3. Industry Performance

4. Emerging Market Trends

5. Key Players

Companies Mentioned:

  • Johnson & Johnson
  • Biogen Idec Inc.
  • Eli Lilly & Company
  • Sanofi-Aventis
  • Merck Serono S.A.
  • Roche Group
  • Amgen Inc.

For more information visit http://www.researchandmarkets.com/research/9bdf9d/global_protein_the



CONTACT:

Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
[email protected]

KEYWORDS:

INDUSTRY KEYWORDS:   Health  Biotechnology  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

In this week's EuroBiotech Report, AstraZeneca plans 2020 lupus filing, Roche's SMA trial hits endpoint and Kiadis cuts staff in R&D pivot.

In our EuroBiotech roundup this week, NEC and Vaximm ink cancer vaccine pact, Compugen posts cancer data and Lunac raises cash.

Biotech venture fund ATAI Life Sciences has partnered with artificial intelligence drug discovery specialist Cyclica to form a new JV.